Cystic fibrosis: clinical management

December 2006
Thorax;Dec2006 Supplement 2, Vol. 61, pii119
Academic Journal
The article presents abstracts of medical research on clinical management of cystic fibrosis. They include "Glucocorticoids As an Adjuvant Treatment to Intravenous Antibiotics for Cystic Fibrosis Pulmonary Exacerbations: A UK Survey," "Influenza Vaccination in Cystic Fibrosis, Any Role?," and "Adult Cystic Fibrosis Lung Function, Nutrition and Survival at the Royal Brompton Hospital Compared With UK and U.S. Data."


Related Articles

  • Method of Classifying Disease Severity May Help Streamline CF Research. Begany, Timothy // Pulmonary Reviews;Nov2006, Vol. 11 Issue 11, p20 

    The article discusses research being done on the significance of classifying disease severity to cystic fibrosis (CF) research. It references a study by M. D. Schluchter and colleagues, published in the 2006 issue of the "American Journal of Respiratory and Critical Care Medicine." It describes...

  • Nonsense mutations: Running the red light. Ainsworth, Claire // Nature;12/8/2005, Vol. 438 Issue 7069, p726 

    The article reports on the clinical trials conducted for PTC124 drug that can treat genetic diseases. The trial was conducted on patients in an Israeli hospital who hopes to cure their cystic fibrosis. PTC124 aims at thwarting a cellular process called nonsense-mediated decay. Research into this...

  • Fixing cystic fibrosis CFTR with correctors and potentiators. Off to a good start. Elborn, J. Stuart // Thorax;Jan2012, Vol. 67 Issue 1, p4 

    The author reflects on the results of several studies on treating cystic fibrosis (CF) with correctors and potentiators. He states that numerous in vitro and animal studies suggests that it is possible to correct the cystic fibrosis transmembrane regulator (CFTR) and will make a significant...

  • Misdiagnosis of Cystic Fibrosis. Rosenstein, Beryl J.; Langbaum, Terry S. // Clinical Pediatrics;Feb1987, Vol. 26 Issue 2, p78 

    A retrospective review was conducted of the charts of 271 patients with a diagnosis of cystic fibrosis (CF) who were evaluated over a 15-year period at the Johns Hopkins Hospital. Among these patients, eight were encountered in which the diagnosis of CF was made on the basis of a compatible...

  • A disease called 'sixty-five roses'.  // Nature Structural Biology;Dec2002, Vol. 9 Issue 12, p887 

    Provides information on cystic fibrosis (CF). Cause of CF; Increase in efforts to educate the public about preventing CF; Initial screen for CF.

  • CYSTIC FIBROSIS NO LONGER A FATAL DISEASE. Braverman, Jane // Exceptional Parent;Nov2001, Vol. 31 Issue 11, p87 

    Provides information on cystic fibrosis. Background on the disease; Life expectancies of patients; Diagnosis of the illness; Treatment of the disease.

  • Activation of the epithelial Na+ channel (ENaC) requires CFTR CI- channel function. Reddy; Light, M.M. // Nature;11/18/1999, Vol. 402 Issue 6759, p301 

    Examines the ion channel regulation in the genetic disease cystic fibrosis. Dependence of epithelial Na+ channel on CFTR activity; Primary defect in Cl- channel permeability in cystic fibrosis; Factors in the reduced salt absorption in cystic fibrosis.

  • Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. Poustie, Vanessa J.; Russell, Jayne R.; Watling, Ruth M.; Ashby, Deborah; Smyth, Rosalind L. // BMJ: British Medical Journal (International Edition);3/18/2006, Vol. 332 Issue 7542, p632 

    Objective To determine whether oral protein energy supplements, used long term in children with cystic fibrosis who are moderately malnourished, improve nutritional and other outcomes. Design Multicentre randomised controlled trial. Setting Seven specialist paediatric cystic fibrosis centres and...

  • PATTERNS OF GI DISEASE IN ADULTHOOD ASSOCIATED WITH MUTATIONS IN THE CFTR GENE. Wilschanski, Michael; Dune, Peter R. // Gut;Aug2007, Vol. 56 Issue 8, p1153 

    The article examines the clinical manifestations of gastrointestinal disease in adults that are associated with mutations in the cystic fibrosis transmembrane regulator (CFTR) protein. It discusses the challenges of establishing or excluding a CF diagnosis in patients who are presented with de...


Read the Article


Sign out of this library

Other Topics